A multidisciplinary treatment approach to plaque psoriasis

shutterstock_1491889880 - image for home page

Ixekizumab provides early, sustained and complete skin clearance in moderate-to-severe psoriasis; learn more about assessing disease severity, treatment priorities, and how a holistic management approach improves quality of life

Learning objectives

You will learn about:

  • The pathogenesis of psoriasis (PsO)
  • The different disease metrics used to assess the severity of PsO
  • Current approaches to the treatment of PsO
  • Clinical and real-world evidence of the safety and efficacy of ixekizumab for the treatment of PsO.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.

To access this module, please register or login: